Cystic fibrosis
Do you want to receive a message when there is new research about cystic fibrosis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication there is one sentence that explains what was studied — and you receive notification as soon as there is new research on Cystic Fibrosis. View what Premium costs.
Publications and studies (2553)
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Redefining Cystic Fibrosis-Related Diabetes Management With Tirzepatide: A Case Report. (2025/11/21) ♡
- The role of salivary biochemical markers and dental indices in the assessment of oral health of Egyptian children with cystic fibrosis: an exploratory study. (2025/11/18) ♡
- CFTR rescue in W1282X cystic fibrosis patient-derived intestinal organoids (PDIOs) mediated by translational readthrough-inducing drugs (TRIDs). (2025/11/17) ♡
- Comprehensive Evaluation of Elexacaftor/Tezacaftor/Ivacaftor in Paediatric Cystic Fibrosis: Nutritional, Pulmonary, and Quality-of-Life Outcomes. (2025/11/10) ♡
- Nanohybridization as a Route to a Water-Friendly Therapeutic Tool for Rescuing Misfolded Proteins. (2025/11/07) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cardiometabolic insights in cystic fibrosis and highly effective modulator therapies: a narrative review. (2025/11/04) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Can Milrinone Be a Therapeutic Alternative in Persistent Pulmonary Hypertension of the Newborn? A Case Series and Narrative Review. (2025/11/03) ♡
- A novel drug series optimized to address cystic fibrosis and other CFTR deficiency diseases of human airways. (2025/11/03) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Use of complementary medicines and self-medication practices in cystic fibrosis - MUCAUTOMED study. (2025/11/01) ♡
- Relationship between skeletal muscle indicators and clinical outcomes in cystic fibrosis is modified by adiposity and CFTR modulator use: a cross-sectional analysis. (2025/11/01) ♡
- Body mass, linear growth, and body composition before and after the introduction of elexacaftor/tezacaftor/ivacaftor among children and adults with cystic fibrosis. (2025/11/01) ♡
- Characterization of Egyptian cystic fibrosis children including genotypes and phenotypes: A single tertiary center experience. (2025/11/01) ♡
- Real-world outcomes after initiation of Elexacaftor/tezacaftor/ivacaftor in an adolescent cohort with cystic fibrosis. (2025/11/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Epidemiological characteristics, disease spectrum and clinical pattern of the Egyptian children with cystic fibrosis; A single center registry. (2025/11/01) ♡
- Assessment of the metabolome across the glucose tolerance spectrum in adults with cystic fibrosis hospitalized for pulmonary exacerbations. (2025/11/01) ♡
- Antisense oligonucleotide targeting the E3 ligase RFFL potentiates CFTR modulator efficacy in CF primary bronchial epithelial cells. (2025/10/31) ♡
- Yoga for psychological outcomes and quality of life in non-cystic fibrosis bronchiectasis: a controlled study. (2025/10/23) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cystic Fibrosis and CFTR Modulators: The Impact on Bone Density, Muscle Mass and Strength in Children and Young Adolescents. (2025/10/23) ♡
- Evaluation of Pancreatic Steatosis in Patients with Celiac Disease. (2025/10/20) ♡
- Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. (2025/10/18) ♡
- Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023. (2025/10/18) ♡
- Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. (2025/10/18) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The geroprotective potential of chalcones. (2025/10/15) ♡
- Challenging the paradigm: non-canonical exoprotease cheating in clinical Pseudomonas aeruginosa isolates. (2025/10/13) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. High Index of Suspicion Has Life-Changing Results in an Older Adult Patient. (2025/10/13) ♡
- Evolution and Outcome of a Pediatric Pulmonary Rehabilitation Program in Hong Kong Over the Past Decade. (2025/10/11) ♡
- Host- and microbial-mediated mucin degradation differentially shape Pseudomonas aeruginosa physiology and gene expression. (2025/10/03) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. A systematic review and meta-analysis of the treatment modalities available for children afflicted from cystic fibrosis. (2025/10/03) ♡
- Clinical and genetic characteristics of diseases caused by CFTR gene mutations in 15 Chinese children: a retrospective analysis. (2025/10/02) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Interleukin-10 family cytokines: key regulators and novel therapeutic targets for respiratory diseases. (2025/10/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Clinico-epidemiological Characteristics of Children with Cystic Fibrosis: a Tertiary Care Experience. (2025/10/01) ♡
- Real-World Evaluation of Outcomes and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Pediatric Patients With Cystic Fibrosis: A Retrospective Study. (2025/10/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Effect of Camel Milk on the Spirometry Parameters of Children With Cystic Fibrosis: The First Double Blind Randomized Clinical Trial. (2025/10/01) ♡
- Risk Factors of Malnutrition in Children with Cystic Fibrosis: A 14-year Retrospective Study from Saudi Arabia. (2025/10/01) ♡
- [Inequalities in access to protein therapy for cystic fibrosis]. (2025/10/01) ♡
- [Newborn screening for cystic fibrosis]. (2025/10/01) ♡
- [The role of imaging in the monitoring of cystic fibrosis]. (2025/10/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Therapeutic revolution for cystic fibrosis]. (2025/10/01) ♡
- [Genetic counseling in cystic fibrosis: what to tell families?]. (2025/10/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Prognostic impact of new treatments for cystic fibrosis]. (2025/10/01) ♡
- [How are patients experiencing the therapeutic paradigm shift in cystic fibrosis?]. (2025/10/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Treatment perspectives for patients not eligible for therapies for cystic fibrosis]. (2025/10/01) ♡
- [Cystic fibrosis: 10 key messages]. (2025/10/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Reflections on 50 Years of Cystic Fibrosis Newborn Screening Experience with Critical Perspectives, Assessment of Current Status, and Predictions for Future Improvements. (2025/09/30) ♡
- Real-life durability and risk factors for biologic discontinuation in pediatric inflammatory bowel disease: results from the SIGENP IBD registry. (2025/09/28) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Pancreatic Enzyme Replacement Therapy: Not Only in Chronic Pancreatitis. (2025/09/26) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Role of the microbiota-gut-lung axis in the pathogenesis of pulmonary disease in children and novel therapeutic strategies. (2025/09/25) ♡
- Dynamics of the Epigenome, Microbiome, and Metabolome in Relation to Early Adiposity in the Maternal-Infant Axis: Protocol for a Prospective, Observational Pilot Study in the Spanish NEMO Cohort. (2025/09/23) ♡
- Exploring the Role of Telemedicine in Duchenne Muscular Dystrophy: Benefits and Challenges. (2025/09/19) ♡
- Diet quality in cystic fibrosis - associations with patient reported outcome measures and enablers and barriers to eating a healthy diet: A protocol paper for a mixed methods study. (2025/09/17) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.